What is the use of migalastat approved by FDA in 2018 August?
migalastat is a pharmacological chaprone that reversibily binds to the active site of alpha galactosidase A protein which is deficient in fabrys disease. Ref:www.pubchem.ncbi.nlm.nih.gov/megalastat.
Fabry's disease
Breast cancer
Glycogen storage disorder
HIV
All India exam